New Am Diabetes Assoc guidelines emphasize a more "personal" approach to setting goals for glycemic control
New Am Diabetes Assoc guidelines emphasize a more "personal" approach to setting goals for glycemic control.
This is due to recent evidence that intensive treatment can lead to NO cardiovascular benefit or HIGHER mortality in some type 2s.
For most type 1s and 2s, the goal is still an A1c < 7%...or estimated average glucose (eAG) less than 154 mg/dL.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote